News
Change - Announcement Of Cessation Of Independent Director
Back
May 07, 2024
Announcement Title | Change - Announcement of Cessation |
Date & Time of Broadcast | May 7, 2024 18:14 |
Status | New |
Announcement Sub Title | Cessation of Independent Director |
Announcement Reference | SG240507OTHRV5S9 |
Submitted By (Co./ Ind. Name) | Lim Yit Keong |
Designation | Lead Independent Director |
Description (Please provide a detailed description of the event in the box below) | This announcement has been reviewed by the Company's sponsor, SAC Capital Private Limited (the "Sponsor"). This announcement has not been examined or approved by the Singapore Exchange Securities Trading Limited ("SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Ms Lee Khai Yinn (Tel: (65) 6232 3210), at 1 Robinson Road, #21-00 AIA Tower, Singapore 048542. |
Additional Details | |
Name Of Person | Dato' Alvin Joseph Nesakumar |
Age | 55 |
Is effective date of cessation known? | Yes |
If yes, please provide the date | 08/05/2024 |
Detailed Reason (s) for cessation | There has been a change in the controlling shareholder of the Company and, as a result, a change to the composition of the Board. Dato Alvin Joseph Nesakumar's ("Dato' Alvin") resignation is to facilitate the appointment of new Board members nominated by the new controlling shareholder, Aurico Global Holdings Pte. Ltd.. Please refer to the Company's announcements dated 17 April 2024 and 7 May 2024 for further information. The Board would like to express its gratitude and appreciation towards Dato Alvin for his contributions to the Board during his tenure. The Sponsor, after having interviewed Dato Alvin, is satisfied that, save as disclosed in this announcement, there are no material reasons for the cessation of Dato Alvin as an Independent Director of the Company. |
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? | No |
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? | No |
Any other relevant information to be provided to shareholders of the listed issuer? | No |
Date of Appointment to current position | 19/06/2023 |
Does the AC have a minimum of 3 members (taking into account this cessation)? | Yes |
Number of Independent Directors currently resident in Singapore (taking into account this cessation) | 3 |
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months | 3 |
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) | Independent Director, Chairman of Remuneration Committee, Member of Audit Committee and Nominating Committee |
Role and responsibilities | Independent Director, Chairman of Remuneration Committee, Member of Audit Committee and Nominating Committee |
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries | Nil |
Shareholding interest in the listed issuer and its subsidiaries? | No |
Past (for the last 5 years) | Malaysian Genomics Resource Centre Berhad MGRC Trading Sdn. Bhd. MGRC Healthcare Sdn. Bhd. MGRC Therapeutics Sdn. Bhd. |
Present | Medi Lifestyle Limited Widuria Sdn. Bhd. 3Logy Media Sdn. Bhd. Aptomed Sdn. Bhd. (dormant) |